ASCO 2014 - Miller - Bevacizumab in the adjuvant treatment of HER2 negative breast cancer

For more free video updates go to www.oncologyeducation.com... Incorporation of Bv into anthracycline and taxane containing adjuvant therapy does not improve IDFS or OS in pts with high risk HER2- breas... Author: oncologyeducation Added: 07/30/2014
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts